Related Experiment Video
Updated: Jan 28, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter
Anubodh S Varshney1, Pratik Manandhar2, Sreekanth Vemulapalli3
1Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, Massachusetts.
Insights
Pre-procedural left ventricular hypertrophy (LVH) patterns did not significantly impact clinical outcomes after transcatheter aortic valve replacement (TAVR). This suggests TAVR benefits patients with severe aortic stenosis irrespective of their LVH status.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Interventional Cardiology
Background:
- Left ventricular hypertrophy (LVH) is common in patients with severe aortic stenosis.
- The impact of different LVH patterns on outcomes after transcatheter aortic valve replacement (TAVR) remains unclear.
Purpose of the Study:
- To investigate the association between pre-procedural LVH patterns and clinical outcomes following TAVR.
- To determine if LVH severity or type influences TAVR success rates.
Main Methods:
- Analysis of a large cohort (n=31,199) from the TVT Registry linked to Medicare data.
- Patients were categorized by LVH patterns (concentric remodeling, concentric LVH, eccentric LVH) using sex-specific criteria.
- Multivariate hazard models assessed the association between LVH patterns and 1-year outcomes (mortality, MI, stroke, new dialysis).
Main Results:
- No significant associations were found between any LVH pattern (concentric remodeling, concentric LVH, eccentric LVH) and adverse outcomes at 1-year follow-up.
- Specific hazard ratios and confidence intervals for mortality, MI, stroke, and new dialysis did not show significant differences compared to patients without LVH.
Conclusions:
- Pre-procedural LVH, assessed by left ventricular mass index and relative wall thickness, is not associated with adverse clinical outcomes 1 year after TAVR.
- TAVR appears to be a beneficial treatment for severe aortic stenosis, regardless of the patient's LVH status.
Objectives:
The aim of this study was to evaluate the association between pre-procedural left ventricular hypertrophy (LVH) patterns and clinical outcomes after transcatheter aortic valve replacement (TAVR).
Background:
The association between pre-procedural LVH pattern and severity and clinical outcomes after TAVR is uncertain.
Methods:
Patients (n = 31,199) across 422 sites who underwent TAVR from November 2011 through June 2016 as part of the Society of Thoracic Surgeons/American College of Cardiology TVT (Transcatheter Valve Therapies) Registry linked with the Centers for Medicare and Medicaid Services database were evaluated by varying LVH patterns, according to sex-specific cutoffs for left ventricular mass index and relative wall thickness. The association between LVH pattern (concentric remodeling, concentric LVH, and eccentric LVH) and outcomes (rates of mortality, myocardial infarction [MI], stroke, new dialysis requirement) at 1-year follow-up were evaluated using multivariate hazard models.
Results:
There were no significant associations between concentric remodeling (death: adjusted hazard ratio [HR]: 1.03; 95% confidence interval [CI]: 0.93 to 1.15; MI: HR: 1.05; 95% CI: 0.76 to 1.46; stroke: HR: 1.11; 95% CI: 0.89 to 1.39; new dialysis: HR: 0.86; 95% CI: 0.64 to 1.15), concentric LVH (death: HR: 1.04; 95% CI: 0.95 to 1.15; MI: HR: 1.12; 95% CI: 0.82 to 1.52; stroke: HR: 1.14; 95% CI: 0.92 to 1.40; new dialysis: HR: 1.17; 95% CI: 0.90 to 1.52), or eccentric LVH (death: HR: 0.98; 95% CI: 0.87 to 1.10; MI: HR: 1.07; 95% CI: 0.71 to 1.63; stroke: HR: 1.01; 95% CI: 0.78 to 1.32; new dialysis: HR: 1.25; 95% CI: 0.92 to 1.70) and outcomes at 1 year compared with patients without LVH.
Conclusions:
In a contemporary cohort of patients who underwent TAVR, pre-procedural LVH according to left ventricular mass index and relative wall thickness was not associated with adverse outcomes at 1-year follow-up. TAVR is likely to benefit patients with severe aortic stenosis regardless of the presence of LVH.
More Related Videos
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Role of Affect in Interpersonal Attraction
The Influence of Affect on Cognition
The Influence of Cognition on Affect
Predicting Reaction Outcomes
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...

